Q: Hello Stellar 5i Team, please help me with AYA. It appears frequently as a top pick even though your latest report is out of date and the stock is up 100% from Sept 2012. True revenue growth is off the charts in part from great but not cheap acquisitions. But the company is not profitable, has therefore no ROE, it no longer has a stellar balance sheet; enormous G&A costs at 75% of revenue offset the appealing 97% GP margin. Annualized cash flow of only $12 million as a percent of market cap an is puny at less than 2%. When will growth translate to high returns on equity and how do you make sense of valuations like the 244x cash flow and over 5x revenue? I have locked in my SUM gains and am attracted to the recent 15% decline in the AYA price but am really struggling with the fundamentals here.
Q: I see that Enghouse is listed in the US as well, as EGHSF:PNK. Its US price history is similar to ESL:T but not the same. Can you tell me why they are different and does it matter which is bought (aside from the different currency risk)?
Q: AYA- I've tried to mirror your model portfolio in the last few months. My aya purchase is now down 15%. I've been told you should sell any stock that drops over 10%. What would you suggest.
Thanks
Could you please rank 5 companies/etfs that you currently cover in terms of which is likely to have the best growth for 2014-15.
Additionally could you share some insight with regards to Badger and CSU as to how the team accurately gauges projected income to better understand true value as the current PE multiples are very high.
Q: I am up substantially on RPI.UN and it is becoming a bigger position in my portfolio than you probably would advocate (pushing 12%). On the other hand, it seems to have broken above a fairly long term resistance level of about $10. Any thoughts about the outlook for the stock would be appreciated as would be your thoughts on when to pull the trigger in such cases.
Q: STN is still rated A in the model portfolio despite its rise in price. What are the ratings based on? I ask because STN is probably not as good a buy as it was a few months ago. Tx in advance.
Q: About aston hill,ahf
I am surprised that this stock has not been doing much.compared to stocks that compare like glusken.
What do you think of the outlook for aston and is it a buy here?
It has a nice dividend, is it save?
Do you also think it will be taken over?
I have held WIN for for a long time and no matter how many deals they seem to sign the litigation costs seem to eat into any revenue gains. Is it time to move on to other opportunities?
Q: Canexus CUS Not a question, just a show of frustration. I bought a small position in this company yesterday. Not blaming anyone but myself, however, I would have preferred wasting the money on Whiskey and Women.
Q: Some people propose screening companies using the following:
*level of compounding capital/level of capital efficiency
*High returns on equity / high profit margins
*Low to no debt
*High levels of mgt ownership
If applied to your say B+ and higher rated companies - which ones look to meet the criteria the closest.
Q: What do you think I should do with Canexus CUS after today's latest stumble? I'm down 25% but receiving a decent dividend. Will it recover over the coming year or so; or should I unload?
Many thanks for your great service.
Q: Hello 5i. I hold an equal number of shares of G and OSK. I seem to be in a position of gaining on the swings and losing on the round-abouts. How would you play this? Sell G because, as you suggest, they may have to raise their offer, and their decline will thereby be hastened while OSK can only gain? As always, I look forward to your reply.